Lembas is a foodtech startup that developed "GLP-1 Edge," a patent-pending peptide ingredient designed to naturally boost the GLP-1 hormone.
Lembas has raised $3.6M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2025.
Lembas's investors include Siddhi Capital, Maia Ventures, FLORA Ventures, fresh.fund, Bluestein Ventures.
Lembas is headquartered in Sheffield, United Kingdom.
Lembas is a foodtech startup that developed "GLP-1 Edge," a patent-pending peptide ingredient designed to naturally boost the GLP-1 hormone.
Lembas is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lembas — Funding & Investors." VCBacked, June 10, 2025, https://www.vcbacked.co/company/lembas. Accessed August 14, 2026.
VCBacked. (2025). Lembas — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lembas
{{cite web |title=Lembas — Funding & Investors |url=https://www.vcbacked.co/company/lembas |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated